First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study. - Watanabe H; Nakane K; Nukaya T; Naiki T; Yasui T; Takahara K; Koie T; Inamoto T; Miyake H (Targeted oncology, 2026)